Biotech firm Bharat Serums and Vaccines (BSV) broke ground for a ₹200 crore bio-pharmaceutical manufacturing plant at Genome Valley in Hyderabad on Thursday.
The facility, to come up on 10 acres, will produce women’s health products, rabies vaccines, immunoglobulins and hormones. It will cater to domestic and export markets, BSV said in a release.
With the facility, BSV aims to increase its capacity to produce injectables with the commissioning of the fill-finish formulation line in phase 1 and an additional multi-product line in phase 2 of the project. In a release, the company said it aims to provide long-term employment opportunities to the people of Telangana as well as upskilling of capabilities.
